Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

Covid-19 : 84 forms

Sorting of results :

COVISAL - Comparison of results, feasibility and acceptability of molecular detection of CoV2-SARS between nasopharyngeal swab samples collected in virological transport media and salivary spit samples

Head : DEMAR Magalie, university laboratory

Version 1
Voir
View
Overview

19

Last update : 01/12/2021

COVISAL - Comparison of results, feasibility and acceptability of molecular detection of CoV2-SARS between nasopharyngeal swab samples collected in virological transport media and salivary spit samples

Head : DEMAR Magalie, university laboratory

Main objective

Comparison of the results obtained by the molecular detection of SARS-CoV2 in the 2 types of samples: nasopharyngeal swab taken from the virological transport medium and salivary spit.

Inclusion criteria

Patient presenting to Cayenne Hospital with an indication to perform a COVID diagnostic test (symptomatology, contact case)
Men and women from 3 years to over 75 years old

Last update : 01/12/2021

Voir
View

COVI-ST - Longitudinal follow-up of the risk of exhaustion, anxiety and quality of life of hospital staff in the context of the COVID-19 pandemic

Head : Guinot Isabelle

Version 1
Voir
View
Overview

20

Last update : 05/05/2021

COVI-ST - Longitudinal follow-up of the risk of exhaustion, anxiety and quality of life of hospital staff in the context of the COVID-19 pandemic

Head : Guinot Isabelle

Main objective

Evaluate the impact of the COVID-19 pandemic on burn-out 2 years after the "CHMS Emergency Response Plan (Plan Blanc)", i.e. as of 06/07/2022

Inclusion criteria

Volunteer hospital staff, having worked at CHMS during the Emergency Response Plan for the COVID-19 pandemic, i.e. from 17/03/2020 to 05/07/2020
- Aged >18 years,
- Not under legal protective measures
- Professional having given free, informed confirmation of their non-objection to
taking part in the study

Last update : 05/05/2021

Voir
View

SARCODO - Evaluation of coagulopathy and endothelial dysfunction as a predictive factor for the severity of SARS-CoV-2/COVID-19 infection

Head : SMADJA David, UMR-S1140 and Biosurgical Research Laboratory (Carpentier Foundation)

Version 1
Voir
View
Overview

21

Last update : 05/05/2021

SARCODO - Evaluation of coagulopathy and endothelial dysfunction as a predictive factor for the severity of SARS-CoV-2/COVID-19 infection

Head : SMADJA David, UMR-S1140 and Biosurgical Research Laboratory (Carpentier Foundation)

Main objective

Study the coagulopathy, vascular lesion and markers for tissue distress to characterise the exacerbation of patients with COVID-19 and identify patient populations who will develop or experience exacerbation of a thromboembolic or microvascular process, but also require curative anticoagulation.

Inclusion criteria

Patients aged at least 18 years
Hospitalised in an intensive care or medicine department for suspected COVID-19.
Patients covered by a social security regime (other than the state welfare scheme)
Patient having been informed of the study and having given their informed consent in writing, or for whom a family member/trusted person has given their agreement

Last update : 05/05/2021

Voir
View

COVITREM-1 - Prognostic value of measuring the activation pathway for Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) in patients hospitalised due to COVID-19

Head : GIBOT Sébastien

Version 1
Voir
View
Overview

22

Last update : 05/06/2021

COVITREM-1 - Prognostic value of measuring the activation pathway for Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) in patients hospitalised due to COVID-19

Head : GIBOT Sébastien

Main objective

Evaluate the prognostic value of initial TREM-1 activation (first measurement collected) on clinical deterioration in patients hospitalised due to COVID-19 in medical, emergency and intensive care departments

Inclusion criteria

Patients aged over 18 years
Hospitalised for less than 3 days for any reason whatsoever, but screened for Covid-19. SARS-CoV-2 infection should be "probable" or "confirmed" according to the definition published on 3 April by Santé Publique France (French Public Health Agency): laboratory confirmation (by positive RT-PCR further to nasopharyngeal sample or any other sample and/or positive serology indicating infection) or by a composite endpoint combining characteristic pulmonary impairment upon imaging and clinical/laboratory effects suggesting viral infection (including: fever, cough, chest pain, and biological inflammatory syndrome, lymphopenia, elevated liver enzymes).
Registered with a social security scheme or a beneficiary of such a scheme
The patient or their representative will have received information on the study and signed the emergency informed consent/inclusion form in compliance with Article L.1122-1-3 of the French Public Health Code (CSP)

Last update : 05/06/2021

Voir
View

EDIFICE - Observational study on the diagnostic evaluation of the intestinal microbiota of French people infected with the Coronavirus

Head : MARTI Guy

Version 1
Voir
View
Overview

23

Last update : 05/05/2021

EDIFICE - Observational study on the diagnostic evaluation of the intestinal microbiota of French people infected with the Coronavirus

Head : MARTI Guy

Main objective

Validate the hypothesis for a relationship between the loss of diversity of the intestinal microbiota and screening positive for COVID-19, by comparing hospitalised COVID-19 positive patients with an exposed French population represented by hospital medical and paramedical personnel

Inclusion criteria

COVID-19 positive patients: hospitalised patients diagnosed with COVID-19 in one of the two investigating sites, and able to provide a stool sample
Exposed subjects: Medical and paramedical personnel working at one of the two investigating sites, having been in direct contact with the patients.
Aged between 18 and 85 years
Subjects able to read the French-language study information leaflet
Patients with social cover

Last update : 05/05/2021

Voir
View

FILO-COVIM - Observational study on the impact of the COVID-19 epidemic on patients with myeloproliferative neoplasms

Head : KILADJIAN Jean-Jacques, CIC 1427

Version 1
Voir
View
Overview

24

Last update : 04/20/2021

FILO-COVIM - Observational study on the impact of the COVID-19 epidemic on patients with myeloproliferative neoplasms

Head : KILADJIAN Jean-Jacques, CIC 1427

Main objective

Describe the rate of serious Coronavirus infections in the different subgroups of patients with myeloproliferative neoplasms defined by ongoing treatment during the epidemic.

Inclusion criteria

Male or female aged 18 years and over
Male or female patient with PV, ET, PMF or MF secondary to PV or ET diagnosed before the
COVID-19 pandemic
Attending an appointment from April 2020

Last update : 04/20/2021

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05